RT @JACCJournals: @SJGreene_md presents #JACC study at #ACC19, showing that most #HrrEF patients do not receive guideline-directed medical…
RT @DrRaniKhatib: Uptitration of Heart Failure medicines. https://t.co/0p6qE3zQw7
@SJGreene_md presents #JACC study at #ACC19, showing that most #HrrEF patients do not receive guideline-directed medical therapy & do not receive target doses. https://t.co/fXNG5BIIN8 https://t.co/6lSvSDWNAd
RT @DrRaniKhatib: Uptitration of Heart Failure medicines. https://t.co/0p6qE3zQw7
RT @gcfmd: Critical target for clinician education, quality improvement, and actionable patient-centered metrics. Hundreds of thousands of…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @DrRaniKhatib: Uptitration of Heart Failure medicines. https://t.co/0p6qE3zQw7
RT @ukcpahf: @UKCPA so true, a true MDT is required to achieve optimal care in heart failure https://t.co/bbhzJ0dbY0
Uptitration of Heart Failure medicines. https://t.co/0p6qE3zQw7
RT @ukcpahf: @UKCPA so true, a true MDT is required to achieve optimal care in heart failure https://t.co/bbhzJ0dbY0
@UKCPA so true, a true MDT is required to achieve optimal care in heart failure
RT @ATRIUMRx: More evidence to demonstrate the need for improved GDMT optimization. Over half of eligible patients had NO uptitration of me…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @ATRIUMRx: More evidence to demonstrate the need for improved GDMT optimization. Over half of eligible patients had NO uptitration of me…
More evidence to demonstrate the need for improved GDMT optimization. Over half of eligible patients had NO uptitration of medication over a 12-month period, despite subtarget doses. #cardiotwitter #cardioed
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @DaveDixonPharmD: This is incredibly disappointing. Strong body of evidence supports the role of #Pharmacists to improve the use of GDMT…
RT @SJGreene_md: In current US practice, major gaps in outpatient titration of HFrEF medical therapy. Few eligible pts ever receive target…
This is incredibly disappointing. Strong body of evidence supports the role of #Pharmacists to improve the use of GDMT in heart failure patients. #justsaying @ACCinTouch
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @SJGreene_md: In current US practice, major gaps in outpatient titration of HFrEF medical therapy. Few eligible pts ever receive target…
RT @DrRajivsankar: https://t.co/R3zl22TZgQ Alarmingly less than optimal doses of Optimal Pharmacological Therapy/GDMT in #HeartFailure. We…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @DrRajivsankar: https://t.co/R3zl22TZgQ Alarmingly less than optimal doses of Optimal Pharmacological Therapy/GDMT in #HeartFailure. We…
RT @shelleyhallmd: Amazingly this simple deficit justifies the field of advanced heart failure. No one does this better than us @ishlt @HFS…
RT @SJGreene_md: In current US practice, major gaps in outpatient titration of HFrEF medical therapy. Few eligible pts ever receive target…
RT @SJGreene_md: In current US practice, major gaps in outpatient titration of HFrEF medical therapy. Few eligible pts ever receive target…
More HFSN in community in USA may help ?
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
https://t.co/R3zl22TZgQ Alarmingly less than optimal doses of Optimal Pharmacological Therapy/GDMT in #HeartFailure. We are all in it together- important to seek aid of pharmacists, GPs, community nurse prescribers to reach maximum tolerated doses
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
RT @gcfmd: Critical target for clinician education, quality improvement, and actionable patient-centered metrics. Hundreds of thousands of…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
RT @tedberei: Another shining example of WHY pharmacists should be empowered. Let’s get going on the collaborative practice agreements. Mos…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @ajaysmd: #Cardiotwitter Let’s remind ourselves to keep uptitrating HF meds at EVERY visit, even if small increments! @gcfmd @jtheywood…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @gcfmd: Critical target for clinician education, quality improvement, and actionable patient-centered metrics. Hundreds of thousands of…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @tedberei: Another shining example of WHY pharmacists should be empowered. Let’s get going on the collaborative practice agreements. Mos…
Another shining example of WHY pharmacists should be empowered. Let’s get going on the collaborative practice agreements. Most HF patients are not seen by specialists. They are in PCP/family practice offices where time is of the essence and their HF often
RT @gcfmd: Critical target for clinician education, quality improvement, and actionable patient-centered metrics. Hundreds of thousands of…
RT @ajaysmd: #Cardiotwitter Let’s remind ourselves to keep uptitrating HF meds at EVERY visit, even if small increments! @gcfmd @jtheywood…
RT @RomitB_MD: Yikes! And I’m certain this is true in the CV clinics as well. A point well made by mentor @JJheart_doc during our morning r…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @SJGreene_md: In current US practice, major gaps in outpatient titration of HFrEF medical therapy. Few eligible pts ever receive target…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @hvanspall: Knowledge-care gaps persist in #HF: among 2588 patients with #HFrEF in the CHAMP-HF registry (@sjgreene_md @javedbutler1), a…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
🙁
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @SJGreene_md: In current US practice, major gaps in outpatient titration of HFrEF medical therapy. Few eligible pts ever receive target…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
Great piece @SJGreene_md
RT @gcfmd: Critical target for clinician education, quality improvement, and actionable patient-centered metrics. Hundreds of thousands of…
RT @SJGreene_md: In current US practice, major gaps in outpatient titration of HFrEF medical therapy. Few eligible pts ever receive target…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
RT @SJGreene_md: In current US practice, major gaps in outpatient titration of HFrEF medical therapy. Few eligible pts ever receive target…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
@cardinvest @rodrigogopar @Sbarrerab @juanpablosal17
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
RT @iamritu: #HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously…
#HFrEF CHAMP-HF #Registry shows Lack of #longitudinal #titration of meds: Over 12 months, <1% of patients were simultaneously treated with target doses of ACEI/ARB/ARNI, beta-blocker, and MRA #DoseResponse #guidelines #failure #ACC19 https://t.co
RT @SJGreene_md: In current US practice, major gaps in outpatient titration of HFrEF medical therapy. Few eligible pts ever receive target…
Sad but true. No matter what the reason for visit is, always have GDMT titration at the back of your head
RT @SJGreene_md: In current US practice, major gaps in outpatient titration of HFrEF medical therapy. Few eligible pts ever receive target…
RT @ajaysmd: #Cardiotwitter Let’s remind ourselves to keep uptitrating HF meds at EVERY visit, even if small increments! @gcfmd @jtheywood…
RT @RomitB_MD: Yikes! And I’m certain this is true in the CV clinics as well. A point well made by mentor @JJheart_doc during our morning r…
#Cardiotwitter Let’s remind ourselves to keep uptitrating HF meds at EVERY visit, even if small increments! @gcfmd @jtheywood @RajeevCMohan @Babar_Basir @IshltPres
RT @RomitB_MD: Yikes! And I’m certain this is true in the CV clinics as well. A point well made by mentor @JJheart_doc during our morning r…
RT @hvanspall: Knowledge-care gaps persist in #HF: among 2588 patients with #HFrEF in the CHAMP-HF registry (@sjgreene_md @javedbutler1), a…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @hvanspall: Knowledge-care gaps persist in #HF: among 2588 patients with #HFrEF in the CHAMP-HF registry (@sjgreene_md @javedbutler1), a…
Such a low hanging fruit ripe for leveraging IT to augment care!
RT @gcfmd: Critical target for clinician education, quality improvement, and actionable patient-centered metrics. Hundreds of thousands of…
RT @JACCJournals: Majority of eligible #HFrEF pts don't receive target doses of med. therapy at any point. In an #ACC19 poster, published i…
RT @hvanspall: Knowledge-care gaps persist in #HF: among 2588 patients with #HFrEF in the CHAMP-HF registry (@sjgreene_md @javedbutler1), a…